Thomas Arnesen
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 94
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 59
- Signaling Pathways in Disease 32
- Cancer-related gene regulation 13
- Chemical Synthesis and Analysis 6
- Glycosylation and Glycoproteins Research 5
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 37
- Geriatrics and Gerontology top 2%
- Microbiology top 5%
-
- Neuropeptides and Animal Physiology 9
- Co-authors
- Rasmus ReeKris GevaertAdrian DrazicHenriette AksnesLine M. MyklebustJan Erik VarhaugJohan R. LillehaugSylvia Varland
- Journals
- Journal of Biological Chemistry (7 papers)Molecular & Cellular Proteomics (5 papers)Nature Communications (5 papers)
- Partner nations
- NorwayUnited StatesBelgium
In The Last Decade
Thomas Arnesen
107 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 3.8k
- Molecular Biology 4.8k
- Cancer Research 952
- Geriatrics and Gerontology 135
- Microbiology 139
Countries citing papers authored by Thomas Arnesen
This map shows the geographic impact of Thomas Arnesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Arnesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Arnesen more than expected).
Fields of papers citing papers by Thomas Arnesen
This network shows the impact of papers produced by Thomas Arnesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Arnesen. The network helps show where Thomas Arnesen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Arnesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 11 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 49 | |
| 14 | 2019 | 18 | |
| 15 | 2018 | 16 | |
| 16 | 2018 | 142 | |
| 17 | 2018 | 60 | |
| 18 | 2018 | 24 | |
| 19 | 2018 | 20 | |
| 20 | 2017 | 13 |
About Thomas Arnesen
Thomas Arnesen is a scholar working on Oncology, Cancer Research, Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 107 papers that have together received 5.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (94 papers), Ubiquitin and proteasome pathways (59 papers), Protease and Inhibitor Mechanisms (37 papers), Signaling Pathways in Disease (32 papers), Cancer-related gene regulation (13 papers), Neuropeptides and Animal Physiology (9 papers), Chemical Synthesis and Analysis (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Oncology (3.8k citations), Molecular Biology (4.8k citations), Cancer Research (952 citations), Geriatrics and Gerontology (135 citations) and Microbiology (139 citations). Thomas Arnesen has collaborated with scholars based in Norway, United States and Belgium. Frequent co-authors include Rasmus Ree, Kris Gevaert, Adrian Drazic, Henriette Aksnes, Line M. Myklebust, Jan Erik Varhaug, Johan R. Lillehaug, Sylvia Varland, Petra Van Damme and Kristian K. Starheim. Their work appears in journals such as Journal of Biological Chemistry, Molecular & Cellular Proteomics, Nature Communications, Trends in Biochemical Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.